This methodology will be used to review literature about peptides. Original research done on humans will be prioritized when evaluating claims about human benefits and harms. We will assign a grade to our findings and also note regulatory information when applicable. We will distinguish between benefits that have been demonstrated in humans, benefits that have shown promise in clinical trials, findings that only have animal or in vitro support, and anecdotal claims (Balshem et al., 2011).

What Question Are You Trying To Answer?

You should always have a question you are trying to answer when reviewing a peptide. Instead of asking "Will this peptide help me?" have a more narrowed-down question. What peptide are you researching, what benefit are you looking for, for whom, and compared with what?

Use PICO to formulate your question: Population, Intervention, Comparison, and Outcome (Richardson et al., 1995).

Once you have formulated your question, look up the peptide you are researching. There are many similar peptides that may have similar effects on the body, but evidence about one compound should not automatically be applied to another.

Make sure you know what peptide you are looking up: its name, amino acid structure when applicable, how it works, and what its regulatory status is. If you are looking at analogs, they should be researched as their own compounds unless the evidence directly supports comparison.

Find Information About Your Peptide

Once you know what you are looking for, it is time to find research on your topic. PubMed/MEDLINE can be used to search biomedical literature. Other useful sources include ClinicalTrials.gov, FDA drug information and prescribing information, and peer-reviewed scientific journals.

Search terms should include the peptide you are looking up and what you want information about, such as randomized trial, clinical trial, half-life, pharmacokinetics, pharmacodynamics, safety, efficacy, adverse effects, receptor, or the specific condition or outcome you are researching.

What Type Of Information Do You Want To Find?

First, I would like to find randomized clinical trials that have been done in humans. These are especially useful for evaluating whether an intervention produces a clinical benefit and for identifying common adverse effects. Randomized trials generally begin as higher-certainty evidence in formal evidence-grading systems, although study limitations can lower confidence in their findings (Balshem et al., 2011; Guyatt et al., 2011).

If there are not any randomized clinical trials, we can look for controlled studies or other studies done in humans.

Pharmacokinetic and pharmacodynamic studies can tell us how the body handles a peptide, how long exposure may last, and what effects it has on receptors, hormones, or other biological measures. These findings can help explain how something works, but they do not automatically prove a meaningful clinical benefit.

We can then look for observational studies and studies done in animals. These can give us useful information but should not be treated as equivalent to randomized clinical trials in humans.

If there are no human studies, we can look at animal and in vitro studies. These can show what a peptide may be able to do biologically, but they should not be used by themselves to conclude that the peptide will provide the same benefit in humans. Evidence can be indirect when the population, intervention, or outcomes differ from the question we actually want to answer (Guyatt et al., 2011).

Lastly, we have anecdotal evidence. This is something people report experiencing while using a peptide. I do not consider this evidence that a peptide works, but it can lead us to questions that can be investigated with stronger research.

Include Studies That

​

• Are done on the peptide you are researching or a clearly identified pharmaceutical form of that peptide.

• Have been published in a peer-reviewed scientific journal whenever possible.

• Use human participants when you are trying to determine whether a peptide benefits humans.

• Include the type of information needed to answer your research question.

• Relate directly to the benefit, outcome, mechanism, or safety question you are trying to evaluate.

• Use current regulatory information when you are trying to determine whether a drug or indication has been approved by the FDA.
   

Exclude Studies That
 

• Come from websites selling peptides or from influencers promoting peptides when those materials are being presented as scientific evidence.

• Study a different peptide and assume those findings automatically apply to the peptide you are researching.

• Use animal or in vitro findings as proof of a clinical benefit in humans.

• Are conference abstracts when a more complete peer-reviewed publication is available.

• Do not provide enough methodological information to evaluate the findings, are not relevant to the question, or have important conflicts of interest that are not transparently disclosed.

• Use certificates, product descriptions, or unrelated studies as substitutes for clinical research.

Evaluate Each Study

There are many things to consider when looking at a study. The items below are some of the things I will look at when reviewing research. Transparent reporting of trial design, conduct, analysis, and results is important for judging the reliability of randomized trials (Hopewell et al., 2025).

• Is the study randomized?

• Was there a placebo or an appropriate control group?

• Was it blinded when blinding was feasible?

• What was the sample size?

• How many subjects were used, and who were they?

• How long did the study last?

• Were objective and clinically relevant measures used?

• Did subjects drop out of the study, and how was missing data handled?

• What did the researchers find, and does the finding translate into a meaningful clinical benefit?

• Who funded the study, and were conflicts of interest disclosed?
   

Differentiate Between How Something Works And Clinical Benefit

Just because a peptide has been shown to raise levels of something in the body, activate a receptor, or change a biomarker does not mean it has a clinical benefit. We need to see whether it improves a person's health, symptoms, function, or the disease or condition being studied. Surrogate or mechanistic outcomes can provide useful information, but they are not automatically equivalent to patient-important outcomes (Guyatt et al., 2011).

Also Look For Harm

When looking at studies that have shown a peptide to be beneficial, we should also look for harm that may occur from taking that peptide. Look for adverse effects, serious adverse events, discontinuations, and other safety findings reported during the study.

If there are no side effects noted, that does not prove the peptide is safe. There may not have been enough subjects to identify uncommon effects, or the study may not have lasted long enough to identify longer-term risks. Small sample sizes can also reduce certainty in an estimate of effect (Guyatt et al., 2011).

Make Sure To Double Check Regulatory Information

Always verify whether a peptide drug has been approved by the FDA rather than taking a vendor's word for it. FDA approval is based on a specific drug and intended use, and FDA evaluates whether the demonstrated benefits outweigh the known and potential risks for the intended population (U.S. Food and Drug Administration, 2025a).

An FDA-approved drug may also be prescribed for an unapproved use, commonly called off-label use. Off-label use is different from FDA approval for that particular use, so the distinction should be clearly stated (U.S. Food and Drug Administration, 2025b).

Grade The Evidence

I will be using the following scale when grading evidence about a peptide. This is an educational grading scale for this project rather than the formal GRADE system. Formal evidence frameworks consider factors such as study design, risk of bias, consistency, directness, precision, and publication bias when judging confidence in a body of evidence (Balshem et al., 2011).

U.S. Food and Drug Administration. (2025b). Understanding unapproved use of approved drugs “off label.” https://www.fda.gov/understanding-unapproved-use-approved-drugs-label